Immunoenhancement Combined with Amphotericin B as Treatment for Experimental Visceral Leishmaniasis

Author:

Murray Henry W.1,Brooks Elaine B.1,DeVecchio Jennifer L.2,Heinzel Frederick P.2

Affiliation:

1. Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021

2. Center for Global Health and Disease, Case Western University School of Medicine, Cleveland, Ohio 44106

Abstract

ABSTRACT To determine if stimulation of Th1-cell-associated immune responses, mediated by interleukin 12 (IL-12) and gamma interferon (IFN-γ), enhance the antileishmanial effect of amphotericin B (AMB), Leishmania donovani -infected BALB/c mice were first treated with (i) exogenous IL-12 to induce IFN-γ, (ii) agonist anti-CD40 monoclonal antibody (MAb) to maintain IL-12 and induce IFN-γ, or (iii) anti-IL-10 receptor (IL-10R) MAb to blockade suppression of IL-12 and IFN-γ. In animals with established visceral infection, low-dose AMB alone (two injections of 1 mg/kg of body weight; total dose, 2 mg/kg) killed 15 to 29% of liver parasites; by themselves, the immunointerventions induced 16 to 33% killing. When the interventions were combined, the leishmanicidal activities increased 3.4-fold (anti-CD40), 6.3-fold (anti-IL-10R), and 9-fold (IL-12) compared with the activities of AMB plus the control preparations; and overall killing (76 to 84%) approximated the 84 to 92% killing effect of 7.5-fold more AMB alone (three injections of 5 mg/kg; total dose, 15 mg/kg). These results suggest that strengthening the host Th1-cell response may be a strategy for the development of AMB-sparing regimens in visceral leishmaniasis.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference41 articles.

1. Balkhy, H. H., and F. P. Heinzel. 1999. Endotoxin fails to induce interferon-γ in endotoxin tolerant mice: deficiencies in both IL-12 heterodimer production and IL-12 responsiveness. J. Immunol.162:3633-3638.

2. Bennett J. E. 2001. Amphotericin B p. 1295-1299. In J. C. Hardman and L. E. Limbird (ed.) Goodman & Gilman's the pharmacological basis of therapeutics 10th ed. McGraw-Hill New York N.Y.

3. Berman, J. D., and D. J. Wyler. 1980. An in vitro model for chemotherapeutic agents in leishmaniasis. J. Infect. Dis.142:83-86.

4. Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans

5. Blanke, T. J., J. R. Little, S. F. Shirley, and R. G. Lynch. 1977. Augmentation of murine immune responses by amphotericin B. Cell. Immunol.33:180-190.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3